Latest filing published 14 Aug 2026 for Edgewise Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Joanne M. Donovan in Edgewise Therapeutics, Inc. Over a trading history stretching from 1 May 2023 to 13 August 2026, the count stands at 18 filings.
Every open-market trade on record is a sale: 9 sales worth €2.2M. Besides market trades, the filings include 9 option exercises. In 2026 alone, the filings show no purchases and 8 sales.
The record was last updated on 14 August 2026 with an option exercise in Edgewise Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations